40 likes | 137 Views
Explore strategic plans for improving adherence in pediatric HIV patients through a randomized controlled trial with 195 children aged 2-13 over a 6-month period. Discover the impact of disclosure on adherence, HRQoL, and functional impairment.
E N D
S.L. van Elsland 1M.O. Kok2R.P.H. Peters 3N. Grobbelaar4M.F. Cotton 1A.M. van Furth 5 1) Stellenbosch University, Cape Town, SA2) VU University, Amsterdam, NL3) ANOVA Health institute, Johannesburg, SA4) ANOVA Health institute, Paarl, SA5) VU University Medical Center, Amsterdam, NL
Multi-method Randomized controlled trial Adherence tool 195 children (2-13 years)6 months follow-up Strategic HIV/AIDS plans Inadequate capacity to deliverLong-term ART dominates health system
ADHERENCE DISCLOSURE Disclosed:Better adherence HRQoL & FI HRQoL Low FI:Non-adherence
THANK YOU! QUESTIONS? Sabine L. van Elsland (MSc, PhD (c))Email: eonore@gmail.comTelephone: +27(0)797753202